Ingersoll Rand — Feb 13, 2025 release

2 Non-GAAP measure (definitions and/or reconciliations in tables below). 2 2025 Guidance 2,3,4,5 Ingersoll Rand is establishing its full-year 2025 guidance. Key Metrics Revenue - Total Ingersoll Rand 3 3-5% Ingersoll Rand (Organic) 2 1-3% Industrial Technologies & Services (Organic) 1-3% Precision & Science Technologies (Organic) 1-3% FX Impact 4 (~2%) M&A 5 ~$300M / ~4% Corporate Costs (~$165M) Adjusted EBITDA 2 $2,130M - $2,190M (+6% - +9%) Adjusted EPS 2 $3.38 - $3.50 (+3% - +6%) Full-year 2025 phasing assumptions: • Total revenue growth of 3-5% expected in both the first and second half of the year. • Phasing of revenue and Adjusted EBITDA consistent with prior years. • FX, based on December 2024 year-end rates, is expected to impact revenue in both the first and second half of the year consistently. • Revenue from completed M&A is expected to be realized primarily in the first half of the year. • Corporate costs are expected to be incurred relatively evenly throughout the year. • Adjusted EPS phasing is consistent with the Adjusted EBITDA phasing. Reconciliations of non-GAAP measures related to full-year 2025 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adj